The Trans-Pacific Partnership

The Trans-Pacific Partnership (TPP) is a proposed free trade agreement under negotiation between Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, the United States and Vietnam. Leaked documents show the U.S. Trade Representative (USTR) is pressuring TPP countries to expand pharmaceutical monopoly protections and trade away access to medicines. Public Citizen and our partners envision a very different Asia-Pacific region partnership--one that advances pharmaceutical access and innovation simultaneously. Through analysis, and advocacy, we are working to spotlight public health and the knowledge economy at the negotiations and helping countries push back against Big Pharma's corporate influence.

Revealed: secret plan to push 'happy' pills

  • MPs probe drugs giant's bid to boost Seroxat
  • Fears over new targets for anti-depressant
Happy pills only make the producer of them happy. A recent Duke university study showed exercise works as well as if not better than anti-depressants; furthermore anti-depressants only mask the symptom by great accelerating the serotonin levels. The proper treatment is to displace animal and trans fats in cellular membranes with the phospholipids that are supposed to be there: various short chain fatty acids in the omega 3 family: ALA, DHA, EPA and GLA; this allows the neurotransmitter receptors to function properly and not "ignore" the already correct level of serotonin in your body.

The medical profession spends more money lobbying the US government than any other sector.